首页> 外文期刊>Journal of atherosclerosis and thrombosis. >Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome
【24h】

Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome

机译:心脏康复对急性冠脉综合征患者高密度脂蛋白介导的胆固醇外流能力和对氧磷酶-1活性的影响

获取原文
           

摘要

Aims : We evaluated whether exercised-based cardiac rehabilitation (CR) can ameliorate the HDL function, i.e., cholesterol efflux capacity (CEC) and paraoxonase-1 activity in patients with acute coronary syndrome (ACS). Methods : This study is a retrospective analysis of stored serum from patients with ACS following successful percutaneous coronary intervention. The CEC, measured by a cell-based ex vivo assay using apolipoprotein B-depleted serum and 3H-cholesterol labeled macrophages and arylesterase activity (AREA) at the onset or early phase of ACS, and the follow-up periods were compared between 69 patients who completed the five-month outpatient CR program (CR group) and 15 patients who did not participate and/or dropped out from CR program (non-CR group). Results : Apolipoprotein A-I (apoA-I) and CEC significantly increased by 4.0% and 9.4%, respectively, in the CR group, whereas HDL-cholesterol and AREA were not changed during the follow-up periods in both groups. Among CR patients, the CEC significantly increased, irrespective of the different statin treatment, while HDL-cholesterol and apoA-I significantly increased in patients treated with rosuvastatin or pitavastatin. Although CEC and AREA were significantly correlated each other, there is a discordance between CEC and AREA for their correlations with other biomarkers. Both CEC and AREA were significantly correlated with apoA-I rather than HDL-cholesterol. Changes in CEC and those in AREA were significantly correlated with those in apoA-I (rho=0.328, p =0.002, and rho=0.428, p <0.0001, respectively) greater than those in HDL-cholesterol (rho=0.312, p = 0.0042,and rho=0.343, p =0.003, respectively). Conclusions : CR can improve HDL function, and it is beneficial for secondary prevention.
机译:目的:我们评估了基于运动的心脏康复(CR)是否可以改善急性冠脉综合征(ACS)患者的HDL功能,即胆固醇外排能力(CEC)和对氧磷酶-1活性。方法:本研究是回顾性分析成功经皮冠状动脉介入治疗后从ACS患者中储存的血清的方法。在ACS发病初期或早期,使用载脂蛋白B耗尽的血清和 3 H-胆固醇标记的巨噬细胞和芳基酯酶活性(AREA),通过基于细胞的离体测定法测量CEC,以下比较了完成五个月门诊CR计划的69例患者(CR组)和未参与和/或退出CR计划的15例患者(非CR组)的随访时间。结果:CR组的载脂蛋白A-I(apoA-I)和CEC分别显着增加4.0%和9.4%,而两组的随访期间HDL-胆固醇和AREA均未改变。在CR患者中,不管他汀类药物的治疗方法不同,CEC均显着升高,而接受瑞舒伐他汀或匹伐他汀治疗的患者的HDL-胆固醇和apoA-I显着升高。尽管CEC和AREA之间存在显着的相关性,但CEC和AREA之间与其他生物标志物的相关性仍存在差异。 CEC和区域均与apoA-I而非HDL-胆固醇显着相关。 CEC和AREA的变化与apoA-I的变化显着相关(rho = 0.328,p = 0.002,rho = 0.428,p <0.0001),高于HDL-胆固醇(rho = 0.312,p = 0.0042,rho = 0.343,p = 0.003)。结论:CR可改善HDL功能,有利于二级预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号